Citrate Dialysate in Online Hemodialfiltration

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions
HemodiafiltrationHeparinHaemodialysisCitrate Reaction
Interventions
PROCEDURE

Pre-dilution online hemodiafiltration with citrate dialysate

After enrollment, all patients began a 2-week run-in period with conventional dialysis fluid containing acetate and the lowest dose of unfractionated heparin. The investigator titrated the heparin dose by reducing the dose step by step, 25% in each step, until the final minimal dose was achieved. The experimental study consisted of 3 phases, 4 weeks in each phase, and the phases were separated by 1-week washout periods. Phase 1 used CD with 50% of the heparin dose of the baseline. Phases 2 and 3 used 25% heparin and no heparin, respectively. New dialyzers were introduced at the beginning of each phase and the heparin dose was resumed during the washout phase. The calcium concentration in the dialysis fluid was kept constant (1.5 mmol/L) to allow evaluation of the effect of CD on calcium balance

PROCEDURE

Post-dilution hemodiafiltration with citrate dialysate

same protocol with post-dilution Ol-HDF in these same patients for the later 12 weeks.

Trial Locations (2)

10300

Faculty of Medicine ,Vajira hospital,Navamindradhiraj University, Bangkok

Faculty of Medicine ,Vajira Hospital, Bangkok

All Listed Sponsors
lead

Bangkok Metropolitan Administration Medical College and Vajira Hospital

OTHER_GOV